RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today announced that it has priced its underwritten public offering of 8,475,000 shares of its common stock at a price of $20.50 per share. The Company has granted the underwriters an option to purchase up to 1,271,250 additional shares of common stock. Gross proceeds to the Company from the Offering are expected to be approximately $173.7 million, before deducting underwriting discounts and commissions and Offering expenses and assuming no exercise by the underwriters of their option to purchase additional shares of common stock. The Company expects to use all or substantially all of the net proceeds from the Offering to repay debt and any remaining proceeds for general corporate purposes.

The Offering is expected to close on October 6, 2020, subject to customary closing conditions.

Citigroup, BofA Securities and J.P. Morgan Securities LLC are acting as joint book-running managers of the Offering. Baird is also acting as a joint book-running manager.

About Owens & Minor, Inc.

Owens & Minor, Inc. (NYSE: OMI) is a global healthcare solutions company with integrated technologies, products, and services aligned to deliver significant and sustained value for healthcare providers and manufacturers across the continuum of care. With approximately 15,400 dedicated teammates serving healthcare industry customers in 70 countries, Owens & Minor helps to reduce total costs across the supply chain by optimizing episode and point-of-care performance, freeing up capital and clinical resources, and managing contracts to optimize financial performance. A FORTUNE 500 company, Owens & Minor was founded in 1882 in Richmond, Virginia, where it remains headquartered today. The company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America.